Qiagen advances in takeover talks with EQT as bidding interest lifts shares
Takeover interest in diagnostics company Qiagen is intensifying as private equity bidders circle the European molecular testing group. The talks are pushing the company's U.S.-listed shares higher and come after Qiagen said it was evaluating strategic options.
Highlights
- Qiagen is in advanced takeover talks with EQT, which has submitted a binding offer exceeding $50 per share, with KKR also bidding.
- Qiagen's U.S.-listed shares rose over 6% after reports of multiple acquisition offers and its ongoing review of strategic options.
- LSEG data values Qiagen at 8.57 billion euros as market interest intensifies in its molecular diagnostics technology segment.
Board weighs bids amid active sale discussions
As reported by Reuters, citing Bloomberg News, Qiagen is in advanced talks to be acquired by Swedish buyout firm EQT, with the company's board meeting this week to decide on a potential deal.Bloomberg News said, citing people familiar with the matter, that EQT has submitted a binding offer of more than $50 per share for Qiagen. U.S. private equity firm KKR has also made a bid, while there is no certainty the discussions will result in a sale to EQT or another buyer.
Qiagen said it does not comment on market rumors or speculation. EQT and KKR did not immediately respond to Reuters requests for comment.
Diagnostics sector interest supports market reaction
Qiagen's U.S.-listed shares were up more than 6% in afternoon trading. LSEG data values the company at 8.57 billion euros.The reported negotiations follow Qiagen's statement that it is evaluating strategic options amid renewed takeover interest. Interest in the diagnostics company has continued through the year, with EQT, Advent and KKR linked in July to a possible acquisition.
Qiagen develops molecular testing and sample-preparation technologies used by research and clinical laboratories, placing it in a segment that remains strategically important for healthcare and life sciences investors.
In our earlier article on EQT’s acquisition drive, we discussed the firm’s agreement to buy U.S. real estate manager Stockbridge as it expands its platform and adds substantial assets under management. We also noted how tougher fundraising conditions and slower exits are pushing private capital groups toward consolidation and larger, multi-strategy scale—context that helps frame EQT’s renewed interest in major deals.
Latest Sweden News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
